Are you believe in ‘A New Era’ in cardiovascular diseases prevention with eicosapentaenoic acid?

A high-dose purified form of the omega-3 oil, eicosapentaenoic acid (EPA), in patients with raised triglycerides who had cardiovascular (CV) disease or diabetes and one additional risk factor has shown a significant benefit, final results of the REDUCE-IT trial show.

As for our understanding, a few later we’ll obligatory meet with the rethinking these results. EPA is the component of the omega-3 oil that in accordance with the 2 × 2 factorial study of cardiovascular events in diabetes has no effect on serious vascular events, cancer or mortality. Due to the Principle of symmetry miracles do not happen.

Leave your comment


This site uses Akismet to reduce spam. Learn how your comment data is processed.

Notify of